The online version of this article (doi:10.1186/1477-7819-10-63) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
EE, SA, HH and KM designed the study; EE and HH collected the data; EE drafted the paper; SA supervised the study; and FW and MD edited and corrected the manuscript. DH (PhD statistician) carried the statistical analysis with the help of MO and CM who participated also in doing some parts of the analysis. All authors read and approved the final manuscript.
In this retrospective study, we evaluated the prognostic effect of positive lymph-node ratio (pLNR) on patients with stage III colorectal cancer (CRC). Our paper is the first analysis, to our knowledge, to deal with such data from the Middle East.
We analyzed the clinicopathological data of 535 patients diagnosed with colorectal cancer at our institution between 1983 and 2003. The 164 patients diagnosed with stage III disease were divided into two categories based on lymph-node ratio (LNR) being the ratio of positive lymph nodes over total lymph nodes dissected: LNR ≤0.4 and LNR >0.4. We used Kaplan-Meier and Cox proportional hazard models to evaluate the prognostic effect of pLNR.
The 10-year survival rate for the patients with stage IIIA, IIIB and IIIC cancers were 76%, 56% and 0% respectively (P = 0.014). Using pLNR of 0.4 as the cutoff point was found to yield clinically and significant results, with a significant difference in the outcomes of patients with pLNR ≤0.4 compared to those with pLNR >0.4 (hazard ratio = 5.25, 95% confidence interval = 1.2 to 22.1, P = 0.02).
The ratio-based staging (pLNR) of CRC is a more accurate and clinically useful prognostic method than the number of positive LNs resected or the total number of LNs retrieved for predicting the course of patients with stage III CRC.
Royal College of Pathologists: Standards and Dataset for Reporting Cancers: Dataset for colorectal cancer (2nd edition). Available at:Accessed on 29, March, 2011., http://www.rcpath.org/resources/pdf/G049-ColorectalDataset-Sep07.pdf
Hatoum HA, Jamali FR, El-Saghir NS: Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol. 2009, 16: 3388-3395. 10.1245/s10434-009-0653-8. CrossRefPubMed
Mariette C, Piessen G, Briez N: The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008, 247: 365-371. 10.1097/SLA.0b013e31815aaadf. CrossRefPubMed
Marchet A, Mocellin S, Ambrosi A, Nitti D: Italian Research Group for Gastric Cancer (IRGGC), et al: The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007, 245: 543-552. 10.1097/01.sla.0000250423.43436.e1. PubMedCentralCrossRefPubMed
Goldstein NS, Sanford W, Coffey M: Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996, 106: 209-216. PubMed
- Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East
Ghassan K Abou-Alfa
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II